Genomic Valley Biotech Share Price Today | Stock Price & Genomic Valley Biotech Share Screener

Track the current stock price of Genomic Valley Biotech with an interactive chart. Analyse GVBL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Genomic Valley Biotech stock quote in one place.

The quote of ₹29.25 sits between the 52-week low of ₹21.85 and the 52-week high of ₹35.58, and the latest session moved 1.28% from the previous close.

Screen Genomic Valley Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GVBL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Biotechnology industry, and it trades under ISIN INE574D01010.

Classification

Identifiers and Leadership

Screen GVBL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹4, down from ₹4 in 2025.

Latest statistics put total assets at ₹4 and shareholder funds at ₹4.

Screen Genomic Valley Biotech income statement and profit fundamentals. Analyze GVBL quarterly results. Genomic Valley Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0, equal to earnings per unit of ₹0.10, at an operating margin of 24%.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹0 and net profit of ₹0.

Screen GVBL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹0.

Over the same period, investing activities provided ₹0 and financing activities provided ₹0.

See Genomic Valley Biotech shareholding pattern with promoter, FII, and DII holdings. Check Genomic Valley Biotech promoter holding and ownership changes for GVBL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 46.06%, foreign institutions 0.00%, domestic institutions 0.00% and the public 51.01%, spread across 2,481 shareholders.

The shareholder count was 2,481 in 2026-Mar, compared with 2,448 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Genomic Valley Biotech. Genomic Valley Biotech dividend yield can be compared with peers and other stocks in the market.

See which indices include Genomic Valley Biotech stock. Check GVBL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Genomic Valley Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Genomic Valley Biotech stock events that may affect GVBL share price, along with derivatives, futures and options activity and sector gainers.

10 corporate actions are listed, the most recent entry being Annual General Meeting dated December 31, 2026, with a record date of December 31, 2026.

It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 29, 2026.

Screen GVBL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 6 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen GVBL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated August 31, 2026 and August 17, 2026.

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.